Table 1.
Baseline characteristics of patients.
| TeleDiet group (n = 30) | Control group (n = 30) | p-value | ||
|---|---|---|---|---|
| Age, years | 58 (7) | 60 (10) | 0.519 | |
| Male sex | 27 (90) | 27 (90) | 1.000 | |
| Body mass index, kg/m2 | 28.2 [25.8, 30.9] | 28.0 [24.4, 30.1] | 0.395 | |
| Current smoker | 11 (37) | 5 (17) | 0.080 | |
| Coronary artery disease | STEMI | 7 (23) | 8 (27) | 0.764 |
| NSTEMI/UAP | 12 (40) | 10 (33) | 0.588 | |
| Procedure performed | PCI | 27 (90) | 28 (93) | 1.000 |
| CABG | 4 (13) | 3 (10) | 1.000 | |
| Comorbidities | Hypertension | 17 (57) | 15 (50) | 0.605 |
| Dyslipidaemia | 28 (93) | 23 (77) | 0.145 | |
| Diabetes | 6 (20) | 8 (27) | 0.542 | |
| Blood tests | LDL-cholesterol, mg/dL | 102 (49) | 106 (42) | 0.718 |
| HDL-cholesterol, mg/dL | 49 (16) | 51 (18) | 0.588 | |
| HbA1c, %b | 5.8 [5.5, 6.1] | 5.7 [5.5, 6.4] | 0.691 | |
| Estimated GFR, mL/min | 80 [72, 97] | 84 [75, 98] | 0.539 | |
| Echocardiographya | Normal ejection fraction (≥ 50%) | 22 (73) | 23 (77) | 0.708 |
| Cardiopulmonary exercise testing | Peak VO2, mL/min/kg | 20.5 [18.1, 23.6] | 21.1 [16.6, 25.9] | 0.833 |
| Medications | ACEi/ARB, ARNI | 19 (63) | 18 (60) | 0.791 |
| Beta blockers | 23 (77) | 16 (53) | 0.058 | |
| Statins | 26 (87) | 28 (93) | 0.671 | |
| Antiplatelets | 30 (100) | 29 (97) | 1.000 | |
| Mediterranean diet score | 32 [30, 37] | 33 [29, 38] | 0.915 |
Values are mean (standard deviation), median [interquartile range] or n (%).
a
Data were obtained from the most recent (up to 6 months prior) echocardiogram at the time of inclusion.
b
n = 55.
ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; ARNI, angiotensin receptor-neprilysin inhibitor; CABG, coronary artery bypass grafting; GFR, glomerular filtration rate; HbA1c, haemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NSTEMI, non-ST-elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction; UAP, unstable angina pectoris; VO2, oxygen consumption.